These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 33231380

  • 1. Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.
    Vaccaro MG, Sarica A, Quattrone A, Chiriaco C, Salsone M, Morelli M, Quattrone A.
    J Neuropsychol; 2021 Sep; 15(3):301-318. PubMed ID: 33231380
    [Abstract] [Full Text] [Related]

  • 2. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A, Pagonabarraga J, Martínez-Horta S, Busteed L, Pascual-Sedano B, Illán-Gala I, Marin-Lahoz J, Aracil-Bolaños I, Pérez-Pérez J, Sampedro F, Bejr-Kasem H, Kulisevsky J.
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [Abstract] [Full Text] [Related]

  • 3. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [Abstract] [Full Text] [Related]

  • 4. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F, Pellicano C, Cravello L, Savini C, Macchiusi L, Pierantozzi M, Stefani A, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [Abstract] [Full Text] [Related]

  • 5. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R.
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [Abstract] [Full Text] [Related]

  • 6. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ, Wieczorek D, Konkel A, Dąbrowska M, Sławek J.
    Psychiatr Pol; 2017 Aug 29; 51(4):647-659. PubMed ID: 28987055
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ.
    Brain; 2005 Jun 29; 128(Pt 6):1247-58. PubMed ID: 15788542
    [Abstract] [Full Text] [Related]

  • 8. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS, Sedlacik J, Boelmans K, Forkert ND.
    Neuroimage Clin; 2018 Jun 29; 20():1037-1043. PubMed ID: 30342392
    [Abstract] [Full Text] [Related]

  • 9. Impaired sequence manipulation in non-demented patients with progressive supranuclear palsy.
    Zhang G, Ma J, Chan P, Ye Z.
    Brain Behav; 2024 May 29; 14(5):e3527. PubMed ID: 38702898
    [Abstract] [Full Text] [Related]

  • 10. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ, Konkel A, Dąbrowska M, Sławek J.
    Neurol Neurochir Pol; 2015 May 29; 49(1):36-40. PubMed ID: 25666771
    [Abstract] [Full Text] [Related]

  • 11. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
    Tommasini L, Bonaccorsi J, Del Prete E, Cintoli S, Pagni C, Mazzucchi S, Palermo G, Morganti R, Frosini D, Siciliano G, Tognoni G, Ceravolo R.
    Clin Neuropsychol; 2023 Aug 29; 37(6):1207-1220. PubMed ID: 35997036
    [Abstract] [Full Text] [Related]

  • 12. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S, Barbagallo G, Bianco MG, Morelli M, Arabia G, Quattrone A, Gasparini S, Cascini GL, Quattrone A.
    Parkinsonism Relat Disord; 2019 Dec 29; 69():23-29. PubMed ID: 31665684
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.
    Nasri A, Sghaier I, Neji A, Gharbi A, Abida Y, Mrabet S, Gargouri A, Djebara MB, Kacem I, Gouider R.
    J Mov Disord; 2024 Apr 29; 17(2):158-170. PubMed ID: 38290492
    [Abstract] [Full Text] [Related]

  • 14. Track density imaging in progressive supranuclear palsy: A pilot study.
    Nigro S, Bianco MG, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Augimeri A, Quattrone A.
    Hum Brain Mapp; 2019 Apr 15; 40(6):1729-1737. PubMed ID: 30474903
    [Abstract] [Full Text] [Related]

  • 15. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M, Cuoco S, Tepedino MF, Cappiello A, Volpe G, Erro R, Santangelo G, Pellecchia MT, Barone P, PSP Salerno study group.
    J Neurol; 2019 Jul 15; 266(7):1727-1735. PubMed ID: 30989369
    [Abstract] [Full Text] [Related]

  • 16. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C, Cerasa A, Castiglioni I, Gallivanone F, Augimeri A, Lopez M, Arabia G, Morelli M, Gilardi MC, Quattrone A.
    J Neurosci Methods; 2014 Jan 30; 222():230-7. PubMed ID: 24286700
    [Abstract] [Full Text] [Related]

  • 17. Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
    Picillo M, Cuoco S, Carotenuto I, Abate F, Erro R, Volpe G, Pellecchia MT, Catricalà E, Cappa S, Barone P.
    PLoS One; 2019 Jan 30; 14(10):e0223621. PubMed ID: 31603934
    [Abstract] [Full Text] [Related]

  • 18. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M, Diehl-Schmid J, Hapfelmeier A, Kontaxopoulou D, Stefanis L, Oertel WH, Bhatia KP, Papageorgiou SG, Höglinger GU.
    Parkinsonism Relat Disord; 2015 Oct 30; 21(10):1264-8. PubMed ID: 26324212
    [Abstract] [Full Text] [Related]

  • 19. Differentiating between common PSP phenotypes using structural MRI: a machine learning study.
    Quattrone A, Sarica A, Buonocore J, Morelli M, Bianco MG, Calomino C, Aracri F, De Maria M, Vescio B, Vaccaro MG, Quattrone A.
    J Neurol; 2023 Nov 30; 270(11):5502-5515. PubMed ID: 37507502
    [Abstract] [Full Text] [Related]

  • 20. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH, Kim M, Kim JS, Youn J, Jang W, Oh E, Lee PH, Koh SB, Ahn TB, Cho JW.
    Parkinsonism Relat Disord; 2019 Sep 30; 66():80-86. PubMed ID: 31307918
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.